PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1304638
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1304638
MicroRNA Market size was valued at USD 1,555.4 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.
MicroRNAs (miRNAs) are endogenous small RNAs that regulate gene expression post-transcriptionally. MiRNA research in allergy is progressing because miRNAs are essential regulators of gene expression and promising biomarker candidates. Moreover, miRNA inhibitors and mimics are currently in preclinical development as novel therapeutic agents. Furthermore, a rise in research into the potential of miRNA biomarkers in diagnosis, therapeutics, and prognosis is projected to favor market expansion.
As a biomarker increasing the use of microRNA is propelling the market. In addition, these biomarkers are significant in data-driven methods and genome-wide population studies because they have high reproducibility and robustness as compared to traditional procedures. Thereby, for the development of biomarkers such molecules are promising drug candidates. Moreover, rising interest in liquid-based biopsies has raised their importance in biomarker discovery and development. However, their toxicity and safety are controversial issues along with the high cost of microRNA will likely act as a restrain which may hamper the market growth during the forecast period. Furthermore, for improving the selectivity and sensitivity of microRNA detection technological innovation contributes to the microRNA market's growth. The newly developed methods for microRNA detection includes DSN-based, nanoparticle-based amplification, enzyme-free amplification, and RCA-based. Similarly, a program-based isothermal amplification technique is developed by researchers for quantitative and specific digital measurement of miRNA. As a result, the system can minimize contamination as it is based on signal amplification rather than direct replication of the targeted sequence as is done with PCR-based approaches.
The global microrna market is segmented on the basis of product & service, application, technology, and region.
The market is divided into three categories based on product & service: products, consumables, and services. The services segment is expected to dominate the market share. Among services, localization & quantification and profiling services held the largest market share. Moreover, PCR instruments are commonly used in life, and science research for miRNA quantification. Furthermore, NGS, microarrays, and real-time PCR are some of the generic used methods for miRNA profiling.
The market is divided into five categories based on application: cancer, infectious diseases, immunological disorder, cardiovascular disease, neurological diseases, and others. The cancer segment is likely to possess the market share over the forecast period. The high investments in cancer research adopting miRNA signatures are resulting in the highest revenue share. Additionally, clinical diagnostic tests for the differentiation of cancer subtypes & the stage and progress in clinical trials for therapies based on miRNA are attributed to fuel the segment growth.
The market is divided into two categories based on end use: biotechnology & pharmaceutical companies, academic & government research institutes, and others. The academic & government research institutes are likely to maintain their dominance. This segment is the essential revenue generator of the miRNA market. MiRNA-associated products and techniques are majorly used in various research studies that are being conducted by academic and research institutes. As a result, a rising number of research studies are expected to propel the market growth.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Market participants in this industry are continuously engaged in the development of novel instruments, kits, and tools with high specificity, reproducibility, and accessibility. Moreover, players in the market have announced novel biologics along with shifting their focus on building a well-developed global distribution network to gain a foothold among these peers. After that, the focus shifted towards inorganic growth, specifically in developed nations, allowing market players to expand at unpredictable rates. For instance, in August 2022, MiRXES launched a series of new capabilities-including an Industry 4.0 (i4.0) manufacturing facility, two new laboratories, and a collaborative multi-cancer screening research project. Additionally, to develop miRNA-based disease detection tests the new developments are aligned with MiRXES' goal of advancing its production and research capabilities.
For instance, in January 2023, Bio-Techne Corporation introduced the RNAscope Plus smRNA-RNA detection assay for the expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ hybridization (ISH) portfolio. Moreover, it is designed to be easily scalable to assist large studies, the assay will be provided for use on the Leica Bond Rx platform and as a manual assay.
This proposed research study on microRNA market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
The report provides the client the latest up-to-date and trending insights about the microRNA market.
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for microRNA market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the microRNA market
Impact of COVID-19 on microRNA market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on microRNA market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the microRNA market, we have also included competitive landscape and key innovator analysis for the microRNA market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the microRNA market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global microRNA market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
The scope of this report covers the market by its major segments, which include as follows: